What 3 layoff stories reveal about pharma’s troubles

The layoff rate across biopharma has remained flat so far this year, said Ural, who’s seeing about 5,000 to 7,000 layoffs reported each month across biopharma in industry media trackers. And the biopharma workforce has stayed at about the same growth pattern since 2005 according to the Bureau of Labor Statistics, Ural said, suggesting there’s an ongoing balance between the number of jobs being created and those being axed, with R&D adding more headcount in recent years.